EMA publishes overview of medicines recommended in 2022
The European Medicines Agency (EMA) has published its key recommendations for marketing authorisations in 2022 in ‘Human Medicines Highlights 2022’.
COVID-19
Tag
Expecting the unexpected – managing the impact of lack of supplies and shortages on the UK pharmaceutical sector
The petrol shortages earlier this quarter disrupted the country and impacted supply and distribution channels across sectors. In this new article we discuss issues affecting our vital UK pharmaceutical supply chain and the ways in which organisations can build resilience.
Applications and Opportunities of Artificial Intelligence in Clinical Decision-making
With the COVID-19 pandemic disrupting medical provision across the globe, healthcare providers urgently need to improve efficiency of patient care. Read our new article to learn how artificial intelligence is being used in clinical decision-making.
PharmaMedic’s COVID-19 Resource Round-Up
Navigating the information overload of COVID-19 is a challenge. In this short update, PharmaMedic rounds up some top resources for individuals, pharma and biotech researchers.